136
Views
42
CrossRef citations to date
0
Altmetric
Editorial

Melanoma differentiation associated gene-7 (mda-7)/IL-24: a ‘magic bullet’ for cancer therapy?

, , , , , , & show all
Pages 577-586 | Published online: 03 May 2007

Bibliography

  • DEGOS L: Differentiation therapy in acute promyelocytic leukemia: European experience. J. Cell. Physiol. (1997) 173:285-287.
  • JIANG H, LIN J, FISHER PB: A molecular definition of terminal cell differentiation in human melanoma cells. Mol. Cell. Different. (1994) 2:221-239.
  • SOBALLE PW, HERLYN M: Cellular pathways leading to melanoma differentiation: therapeutic implications. Melanoma Res. (1994) 4:213-223.
  • SCOTT RE: Differentiation, differentiation/gene therapy and cancer. Pharmacol. Ther. (1997) 73:51-65.
  • SACHS L: Cell differentiation and bypassing of genetic defects in the suppression of malignancy. Cancer Res. (1987) 47:1981-1986.
  • SACHS L: Cell differentiation and tumour suppression. Ciba Found. Symp. (1989) 142:217-231; discussion 231-233.
  • SACHS L: The control of growth and differentiation in normal and leukemic blood cells. Cancer (1990) 65:2196-2206.
  • LESZCZYNIECKA M, ROBERTS T, DENT P, GRANT S, FISHER PB: Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol. Ther. (2001) 90:105-156.
  • FISHER PB, GRANT S: Effects of interferon on differentiation of normal and tumor cells. Pharmacol. Ther. (1985) 27:143-166.
  • FISHER PB, PRIGNOLI DR, HERMO H JR, WEINSTEIN IB, PESTKA S: Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. J. Interferon Res. (1985) 5:11-22.
  • GRAHAM GM, GUARINI L, MOULTON TA et al.: Potentiation of growth suppression and modulation of the antigenic phenotype in human melanoma cells by the combination of recombinant human fibroblast and immune interferons. Cancer Immunol. Immunother. (1991) 32:382-390.
  • GUARINI L, GRAHAM GM, JIANG H et al.: Modulation of the antigenic phenotype of human melanoma cells by differentiation-inducing and growth-suppressing agents. Pigment Cell Res. (1992) (Suppl. 2):123-131.
  • GUARINI L, TEMPONI M, EDWALDS GM et al.: In vitro differentiation and antigenic changes in human melanoma cell lines. Cancer Immunol. Immunother. (1989) 30:262-268.
  • JIANG H, SU Z-Z, BOYD J, FISHER PB: Gene expression changes associated with reversible growth suppression and the induction of terminal differentiation in human melanoma cells. Mol. Cell. Different. (1993) 1:41-66.
  • JIANG H, LIN JJ, SU ZZ, GOLDSTEIN NI, FISHER PB: Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene (1995) 11:2477-2486.
  • JIANG H, SU ZZ, LIN JJ et al.: The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc. Natl. Acad. Sci. USA (1996) 93:9160-9165.
  • HUANG EY, MADIREDDI MT, GOPALKRISHNAN RV et al.: Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene (2001) 20:7051-7063.
  • PESTKA S, KRAUSE CD, SARKAR D et al.: Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. (2004) 22:929-979.
  • CAUDELL EG, MUMM JB, POINDEXTER N et al.: The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J. Immunol. (2002) 168:6041-6046.
  • SAUANE M, GOPALKRISHNAN RV, SARKAR D et al.: MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev. (2003) 14:35-51.
  • DUMOUTIER L, LEEMANS C, LEJEUNE D, KOTENKO SV, RENAULD JC: Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol. (2001) 167:3545-3549.
  • WANG M, TAN Z, ZHANG R, KOTENKO SV, LIANG P: Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J. Biol. Chem. (2002) 277:7341-7347.
  • WOLK K, KUNZ S, ASADULLAH K, SABAT R: Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol. (2002) 168:5397-5402.
  • POINDEXTER NJ, WALCH ET, CHADA S, GRIMM EA: Cytokine induction of interleukin-24 in human peripheral blood mononuclear cells. J. Leukoc. Biol. (2005) 78:745-752.
  • SU ZZ, MADIREDDI MT, LIN JJ et al.: The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc. Natl. Acad. Sci. USA (1998) 95:14400-14405.
  • LEBEDEVA IV, SU ZZ, SARKAR D et al.: Melanoma differentiation associated gene-7, mda-7/interleukin-24, induces apoptosis in prostate cancer cells by promoting mitochondrial dysfunction and inducing reactive oxygen species. Cancer Res. (2003) 63:8138-8144.
  • LEBEDEVA IV, SU ZZ, CHANG Y et al.: The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene (2002) 21:708-718.
  • LEBEDEVA IV, SU ZZ, SARKAR D, FISHER PB: Restoring apoptosis as a strategy for cancer gene therapy: focus on p53 and mda-7. Semin. Cancer Biol. (2003) 13:169-178.
  • LEBEDEVA IV, SAUANE M, GOPALKRISHNAN RV et al.: mda-7/IL-24: exploiting cancer’s Achilles’ heel. Mol. Ther. (2005) 11:4-18.
  • GUPTA P, SU ZZ, LEBEDEVA IV et al.: mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine. Pharmacol. Ther. (2006) 111:596-628.
  • FISHER PB: Is mda-7/IL-24 a ‘magic bullet’ for cancer? Cancer Res. (2005) 65:10128-10138.
  • FISHER PB, GOPALKRISHNAN RV, CHADA S et al.: mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic. Cancer Biol. Ther. (2003) 2:S23-S37.
  • SARKAR D, SU ZZ, LEBEDEVA IV et al.: mda-7 (IL-24): signaling and functional roles. Biotechniques (2002) (Suppl.):30-39.
  • SU Z, LEBEDEVA IV, GOPALKRISHNAN RV et al.: A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells. Proc. Natl. Acad. Sci. USA (2001) 98:10332-10337.
  • LEBEDEVA IV, SARKAR D, SU ZZ et al.: Molecular target-based therapy of pancreatic cancer. Cancer Res. (2006) 66:2403-2413.
  • LEBEDEVA IV, SU ZZ, SARKAR D et al.: Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis. Oncogene (2005) 24:585-596.
  • SAUANE M, GOPALKRISHNAN RV, LEBEDEVA I et al.: Mda-7/IL-24 induces apoptosis of diverse cancer cell lines through JAK/STAT-independent pathways. J. Cell. Physiol. (2003) 196:334-345.
  • SAUANE M, GUPTA P, LEBEDEVA IV et al.: N-glycosylation of MDA-7/IL-24 is dispensable for tumor cell-specific apoptosis and ‘bystander’ antitumor activity. Cancer Res. (2006) 66:11869-11877.
  • SAUANE M, LEBEDEVA IV, SU ZZ et al.: Melanoma differentiation associated gene-7/interleukin-24 promotes tumor cell-specific apoptosis through both secretory and nonsecretory pathways. Cancer Res. (2004) 64:2988-2993.
  • SARKAR D, SU ZZ, LEBEDEVA IV et al.: mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc. Natl. Acad. Sci. USA (2002) 99:10054-10059.
  • GUPTA P, WALTER MR, SU ZZ et al.: BiP/GRP78 Is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis. Cancer Res. (2006) 66:8182-8191.
  • SU ZZ, LEBEDEVA IV, SARKAR D et al.: Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene (2003) 22:1164-1180.
  • PATAER A, VORBURGER SA, BARBER GN et al.: Adenoviral transfer of the melanoma differentiation-associated gene 7(mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res. (2002) 62:2239-2243.
  • PATAER A, VORBURGER SA, CHADA S et al.: Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR. Mol. Ther. (2005) 11:717-723.
  • YACOUB A, MITCHELL C, HONG Y et al.: MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells. Cancer Biol. Ther. (2004) 3:739-751.
  • YACOUB A, MITCHELL C, LEBEDEVA IV et al.: mda-7 (IL-24) Inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling. Cancer Biol. Ther. (2003) 2:347-353.
  • YACOUB A, MITCHELL C, LISTER A et al.: Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo. Clin. Cancer Res. (2003) 9:3272-3281.
  • EMDAD L, LEBEDEVA IV, SU ZZ et al.: Combinatorial treatment of non-small-cell lung cancers with gefitinib and Ad.mda-7 enhances apoptosis-induction and reverses resistance to a single therapy. J. Cell. Physiol. (2007) 210:549-559.
  • LEBEDEVA IV, SARKAR D, SU ZZ et al.: Bcl-2 and Bcl-xL differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24. Oncogene (2003) 22:8758-8773.
  • SU ZZ, LEBEDEVA IV, SARKAR D et al.: Ionizing radiation enhances therapeutic activity of mda-7/IL-24: overcoming radiation- and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2. Oncogene (2006) 25:2339-2348.
  • MHASHILKAR AM, STEWART AL, SIEGER K et al.: MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells. Mol. Ther. (2003) 8:207-219.
  • GOPALAN B, LITVAK A, SHARMA S et al.: Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells. Cancer Res. (2005) 65:3017-3024.
  • SAEKI T, MHASHILKAR A, SWANSON X et al.: Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo. Oncogene (2002) 21:4558-4566.
  • NISHIKAWA T, RAMESH R, MUNSHI A, CHADA S, MEYN RE: Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation. Mol. Ther. (2004) 9:818-828.
  • RAMESH R, MHASHILKAR AM, TANAKA F et al.: Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res. (2003) 63:5105-5113.
  • EMDAD L, SARKAR D, LEBEDEVA IV et al.: Ionizing radiation enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human ovarian cancer. J. Cell. Physiol. (2006) 208:298-306.
  • KAWABE S, NISHIKAWA T, MUNSHI A et al.: Adenovirus-mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms. Mol. Ther. (2002) 6:637-644.
  • SU Z, EMDAD L, SAUANE M et al.: Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells. Oncogene (2005) 24:7552-7566.
  • SARKAR D, SU ZZ, VOZHILLA N et al.: Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice. Proc. Natl. Acad. Sci. USA (2005) 102:14034-14039.
  • CHEN WY, CHENG YT, LEI HY et al.: IL-24 inhibits the growth of hepatoma cells in vivo. Genes Immun. (2005) 6:493-499.
  • FISHER PB, SARKAR D, LEBEDEVA I et al.: Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma. Toxicol. Appl. Pharmacol. (2007) (In Press).
  • CUNNINGHAM CC, CHADA S, MERRITT JA et al.: Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a Phase I study. Mol. Ther. (2005) 11:149-159.
  • TONG AW, NEMUNAITIS J, SU D et al.: Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol. Ther. (2005) 11:160-172.
  • RAMESH R, ITO I, SAITO Y et al.: Local and systemic inhibition of lung tumor growth after nanoparticle-mediated mda-7/IL-24 gene delivery. DNA Cell Biol. (2004) 23:850-857.
  • MAHASRESHTI PJ, KATARAM M, WU H et al.: Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapy. Gynecol. Oncol. (2006) 100:521-532.
  • ZHAO L, GU J, DONG A et al.: Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer. Hum. Gene Ther. (2005) 16:845-858.
  • ZERBINI LF, CZIBERE A, WANG Y et al.: A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cells. Cancer Res. (2006) 66:11922-11931.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.